Boston to curb insurance coverage of GLP-1 drugs for city workers
The PEC voted unanimously on Tuesday to let the city change its Blue Cross Blue Shield of Massachusetts…
India’s coming Ozempic moment could reshape both waistlines and perceptions
On a recent episode of CBS Sports Golazo, Clint Dempsey couldn’t resist a dig. Sitting alongside Thierry Henry,…
Don't advertise weight-loss drugs: Govt to pharma firms | 'Obesity 'awareness campaigns' also misleading' | Inshorts – Inshorts
Don’t advertise weight-loss drugs: Govt to pharma firms | ‘Obesity ‘awareness campaigns’ also misleading’ | Inshorts InshortsCDSCO issues advisory…
What Big Pharma Won’t Tell You: The Ancient Natural Remedy People Swear By — and It Costs Almost Nothing
Claims that “Big Pharma doesn’t want you to know” about a powerful, nearly free natural remedy circulate widely…
NHS must keep medicine rebate down or lose investment
Wednesday 18 February 2026 2:27 pm | Updated: Wednesday 18 February 2026 3:10 pm Share Facebook Share on Facebook…
Irish exports hit record high last year as companies rushed to beat Trump’s tariffs – The Irish Times
The value of Irish exports went up by 16.4 per cent last year to a record €260.3 billion,…
Agentic AI in healthcare: How Life Sciences marketing could achieve $450B in value by 2028
Agentic AI in healthcare is graduating from answering prompts to autonomously executing complex marketing tasks – and life…
US-UK pharma deal isn’t enough to get AstraZeneca investing in Britain again – POLITICO
“It will probably not be sufficient for many of these fully innovative products,” he said. “We need to…
Roche details non-inferiority of BTK inhibitor in multiple sclerosis trial – Endpoints News
Roche details non-inferiority of BTK inhibitor in multiple sclerosis trial Endpoints NewsRoche unveils data behind BTK inhibitor’s phase 3…
GSK’s new CEO eyes more dealmaking, intense pipeline inspection – Endpoints News
GSK’s new CEO eyes more dealmaking, intense pipeline inspection Endpoints NewsGSK (FY Results): another step towards mid-term target Hargreaves LansdownGSK…
China’s new commercial insurance model could broaden access to Alzheimer’s drugs
China’s new commercial insurance formulary looks to expand patient access to Alzheimer’s disease medicines from Eli Lilly and…
UK lowers new medicine rebate scheme to 14.5% for 2026 – Endpoints News
UK lowers new medicine rebate scheme to 14.5% for 2026 Endpoints NewsWhat will be the cost of Keir Starmer’s…